Janux Therapeutics (JANX) Research & Development (2020 - 2025)
Historic Research & Development for Janux Therapeutics (JANX) over the last 6 years, with Q3 2025 value amounting to $34.6 million.
- Janux Therapeutics' Research & Development rose 8603.74% to $34.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $115.2 million, marking a year-over-year increase of 9249.12%. This contributed to the annual value of $68.4 million for FY2024, which is 2451.84% up from last year.
- Per Janux Therapeutics' latest filing, its Research & Development stood at $34.6 million for Q3 2025, which was up 8603.74% from $34.7 million recorded in Q2 2025.
- Janux Therapeutics' 5-year Research & Development high stood at $34.7 million for Q2 2025, and its period low was $1.9 million during Q1 2021.
- In the last 5 years, Janux Therapeutics' Research & Development had a median value of $14.1 million in 2022 and averaged $15.6 million.
- In the last 5 years, Janux Therapeutics' Research & Development surged by 103390.86% in 2021 and then crashed by 2068.81% in 2023.
- Over the past 5 years, Janux Therapeutics' Research & Development (Quarter) stood at $11.2 million in 2021, then soared by 38.19% to $15.4 million in 2022, then dropped by 20.69% to $12.2 million in 2023, then skyrocketed by 69.97% to $20.8 million in 2024, then surged by 66.44% to $34.6 million in 2025.
- Its Research & Development stands at $34.6 million for Q3 2025, versus $34.7 million for Q2 2025 and $25.1 million for Q1 2025.